Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | MPO | P05164 | 6/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.55 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.52 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 4/20 | 0.45 |
| ▸ | CA2 | P00918 | 4/20 | 0.45 |
| ▸ | CA9 | Q16790 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1171657 | 0.93 | TAAR1 (0.54) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL9116334 | 0.91 | MGLL (0.56) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL1171532 | 0.91 | MGLL (0.56) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL16238934 | 0.91 | MGLL (0.56) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL990719 | 0.86 | TAAR1 (0.60) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL29788064 | 0.86 | TAAR1 (0.60) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL3800530 | 0.85 | TAAR1 (0.65) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL4967651 | 0.85 | TAAR1 (0.65) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL8402231 | 0.83 | MGLL (0.66) | TAAR1MPOSLC6A4HSPA5MGLL | |
| SCHEMBL8401990 | 0.83 | MGLL (0.66) | TAAR1MPOSLC6A4HSPA5MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220144888-A1 | PEPTIDE PURIFICATION METHOD USING SULFONATE COMPOUND | NAGASE & CO., LTD. (JP) | 2022-05-12 | — | — | US | disclosed |
| CN-109641918-B | Imidazoles as inhibitors of histone demethylases | 欧洲肿瘤研究所有限责任公司 | 2021-12-21 | — | — | CN | disclosed |
| EP-3851446-A1 | PEPTIDE PURIFICATION METHOD USING SULFONATE COMPOUND | Nagase & Co., Ltd. (JP) | 2021-07-21 | — | — | EP | disclosed |
| EP-3615506-A1 | NOVEL COMPOUNDS OF FORMULA (I) AND USE THEREOF IN THERMOCHROMIC PIGMENT COMPOSITIONS | Société BIC (FR) | 2020-03-04 | — | — | EP | disclosed |
| CN-109641918-A | Imidazoles as inhibitors of histone demethylases | 欧洲肿瘤研究所有限责任公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-102212085-A | Method for preparing Salen-metal complex | UNIV HEBEI TECHNOLOGY | 2011-10-12 | — | — | CN | disclosed |
| EP-1879562-A2 | PHENOL DERIVATIVES AND THEIR USE TO MODULATE PKB ACTIVITY | Imperial Innovations Limited (GB) | 2008-01-23 | — | — | EP | disclosed |
| WO-2006097744-A2 | PHENOL DERIVATIVES AND THEIR USE TO MODULATE PKB ACTIVITY | IMPERIAL INNOVATIONS LIMITED (GB) | 2006-09-21 | — | — | WO | disclosed |
| EP-0619374-B1 | Colorimetric determination of an analyte using benzyl alcohol dehydrogenase and a chromogenic redox-indicator | BOEHRINGER MANNHEIM GMBH (DE) | 1997-08-13 | — | — | EP | disclosed |
| US-5639776-A | CROP PESTICIDE; NONPHYTOTOXIC, KIDNEY BEANS, ORANGES | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1997-06-17 | — | — | US | disclosed |
| EP-0751130-A1 | 4,5-DIHYDROPYRAZOLE-5-THIONE DERIVATIVES AND ACARICIDE CONTAINING THE SAME | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1997-01-02 | — | — | EP | disclosed |
| US-5445943-A | Reduction of an aromatic nitrosoaniline compound to a colored quinone diimine | BOEHRINGER MANNHEIM GMBH (DE) | 1995-08-29 | — | — | US | disclosed |
| EP-0619374-A2 | Colorimetric determination of an analyte using benzyl alcohol dehydrogenase and a chromogenic redox-indicator | Roche Diagnostics GmbH (DE) | 1994-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220144888-A1 | PEPTIDE PURIFICATION METHOD USING SULFONATE COMPOUND | VIP, IAPP, RPS27A | TAAR1 4329/4885MPO 3200/4885SLC6A4 2177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.